Antibiotic therapy attenuates colitis in interleukin 10 gene–deficient mice
- 1 June 2000
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 118 (6) , 1094-1105
- https://doi.org/10.1016/s0016-5085(00)70362-3
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pylori vacuolating toxin.Journal of Clinical Investigation, 1998
- Helicobacter hepaticus does not potentiate colitis in interleukin-10 deficient miceGastroenterology, 1998
- Effects of antibiotics on the initiation and perpetuation of colitis in the IL-10 KO miceGastroenterology, 1998
- Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.Journal of Clinical Investigation, 1996
- Ulcerative colitis-like disease in mice with a disrupted interleukin-2 geneCell, 1993
- Interleukin-10Annual Review of Immunology, 1993
- Influence of Infant Diets on the Ecology of the Intestinal Tract of Human Flora-Associated MiceJournal of Pediatric Gastroenterology and Nutrition, 1992
- Double blind, placebo controlled trial of metronidazole in Crohn's disease.Gut, 1991
- Relation between concentrations of metronidazole and Bacteroides spp in faeces of patients with Crohn's disease and healthy individuals.Journal of Clinical Pathology, 1981
- Influence of neomycin and metronidazole on colonic microflora of volunteersJournal of Antimicrobial Chemotherapy, 1979